That broader availability though still limited may be what's driving GLP-1 usage higher overall
In 2026, several BCBS companies announced changes to their coverage of GLP-1s, including Zepbound
Hinton W, Ansari AS, Whyte MB, et al
Our related article on GLP-1 Signaling, the Microbiome, and Hormones explains why GLP-1 biology is part of a larger metabolic network rather than a stand-alone weight-loss switch
While ZipHealth wins out in price in a general sense, each of the three competitors may offer better price points for certain products at certain dosages and quantities
however, the precise mechanisms are still under investigation